|
 |
 |
|
 |
 |
|
MARCH
7-9, 2007
Focus on Fungal Infections 17
San
Diego, California
Manchester Grand Hyatt San Diego
Chairs:
Elias J. Anaissie, MD
University of Arkansas for Medical Sciences
Little Rock, Arkansas
Michael
G. Rinaldi, PhD
University of Texas Health Science Center at San
Antonio
San Antonio, Texas
Click
here to register for this program
|
 |
|
I N V I T A T I O N |
 |
|
|
Dear Colleague:
It
is with great pleasure and enthusiasm that
we invite you to attend “Focus on
Fungal Infections 17” scheduled for
March 7-9, 2007 in San Diego, California.
Year after year, this conference enjoys
great success and has become an international
forum for world leaders in mycology and
infectious disease management to share their
knowledge of fungal infections and how to
optimize patient care.
“Focus”
recognizes both the clinical and the laboratory
aspects of antifungal therapy and offers
a variety of educational tools to instruct
its diverse audience. Expert academicians,
private practice physicians, laboratory
specialists, and specialized veterinarians
will share the newest information through
a combination of lectures, case studies,
poster abstracts and a mycology workshop.
This year, special sessions will be held
on antifungal trial design and on bridging
the gap from pets to humans and back to
pets. Eminent infectious disease specialist
William Dismukes, MD, will touch on the
highlights of his 30-year career with lessons
learned in the management of fungal infections
in various hosts.
In
addition, the Scientific Committee annually
recognizes the efforts of researchers who
make significant contributions in medical
mycology through esteemed and highly competitive
awards for both established and young investigators.
We invite you to submit your studies for
consideration.
This
year we will enjoy the natural and cultural
beauties of San Diego, California, California's
second largest city. Bordered by Mexico,
the Pacific Ocean, the Anza-Borrego Desert
and the Laguna Mountains, San Diego offers
immense options for visitors. We hope you
complement your meeting experience with
some time to enjoy this beautiful city.
We
hope you will join us for two and half days
of learning at Focus on Fungal Infections
17. We know you will thoroughly enjoy this
educational experience!
Sincerely,
Elias
J. Anaissie, MD and Michael G. Rinaldi,
PhD
|
|
|
|
F A C U L T Y |
|
|
| Elias
J. Anaissie, MD
University of Arkansas for Medical Sciences
Little Rock, Arkansas
David
R. Andes, MD
University of Wisconsin
Madison Medical School
Madison, Wisconsin
Robert
W. Bradsher, MD
University of Arkansas for Medical Sciences
Little Rock, Arkansas
William
E. Dismukes, MD
University of Alabama, Birmingham
Birmingham, Alabama
George
L. Drusano, MD
Ordway Research Institute
Albany, New York
John
E. Edwards, MD
Harbor UCLA Medical Center
Los Angeles, California
Annette
W. Fothergill, MA, MBA
University of Texas Health Science Center
at San Antonio
San Antonio, Texas
John
R. Graybill, MD
University of Texas Health Science Center
at San Antonio
San Antonio, Texas
Paul
O. Gubbins, PharmD
University of Arkansas for Medical Sciences
Little Rock, Arkansas
James
Ito, MD
City of Hope National Medical Center
Duarte, California
Carol
A. Kauffman, MD
University of Michigan Medical School and
Veteran Affairs
Ann Arbor, Michigan
|
Shigeru
Kohno, MD, PhD
Nagasaki University Graduate School of Biomedical
Sciences
Nagasaki, Japan
Dimitrios
P. Kontoyiannis, MD, ScD
The University of Texas MD Anderson Caner
Center
Houston, Texas
Kieren
A. Marr, MD
Fred Hutchinson Cancer Research Center
Seattle, Washington
Marcio
Nucci, MD, PhD
Universidade Federal do Rio de Janeiro
Rio de Janeiro, Brazil
Luis
Ostrosky-Zeichner, MD, FACP
University of Texas Health Science Center
at Houston
Houston, Texas
Peter
G. Pappas, MD
University of Alabama Birmingham
Birmingham, Alabama
Jan
E. Patterson, MD
University of Texas Health Science Center
at San Antonio
San Antonio, Texas
Thomas
F. Patterson, MD, FACP
University of Texas Health Science Center
at San Antonio
San Antonio, Texas
John
R. Perfect, MD
Duke University Medical Center
Durham, North Carolina
Michael
A. Pfaller, MD
University of Iowa College of Medicine
Iowa City, Iowa
|
Michael
G. Rinaldi, PhD
University of Texas Health Science Center
at San Antonio
San Antonio, Texas
Coleman M. F. Rotstein, MD, FRCPC, FACP,
FIDSA
Henderson General Hospital
Hamilton, Ontario, Canada
Robert
J. Rubin, MD
Harvard Medical School
Boston, Massachusetts
Brahm
H. Segal, MD
Roswell Park Cancer Institute
Buffalo, New York
Jack
D. Sobel, MD
Wayne State University School of Medicine
Detroit, Michigan
David
A. Stevens, MD
Stanford University School of Medicine
San Jose, California
Deanna
A. Sutton, PhD
University of Texas Health Science Center
at San Antonio
San Antonio, Texas
Ronald
C. Walker, MD
University of Arkansas for Medical Sciences
Little Rock, Arkansas
Thomas
J. Walsh, MD
National Cancer Institute
National Institutes of Health
Bethesda, Maryland
John
R. Wingard, MD
University of Florida College of Medicine
Gainesville, Florida
|
|
|
|
S C I E N T I F I C A G E N D A |
|
|
|
Wednesday, March 7, 2007
2:00
pm
Mycology workshop
Deanna A. Sutton, PhD
Annette W. Fothergill, MA, MBA
4:00
pm
Adjourn
4:05
pm
Satellite symposium
6:05
pm
Reception and poster viewing
Thursday,
March 8, 2007
8:00
am
Welcome and introductory remarks
Elias J. Anaissie, MD
Session
I: Risk factors and epidemiology
Moderators: John E. Edwards, MD and Jan
E. Patterson, MD
8:10
am
Epidemiological trends in invasive fungal
infections: The TRANSNET database
with update on the outbreak of keratitis
with Fusarium spp.
Peter G. Pappas, MD
8:30
am
Notable trends in antifungal drug resistance
Michael A. Pfaller, MD
8:50 am
All aspergilli are not created equal
Kieren A. Marr, MD
9:10 am
Underappreciated risk factors for invasive
mould infections
Dimitrios P. Kontoyiannis, MD, ScD
9:30
am
Panel discussion
9:50
am
Coffee break
Session
II: Bridging the gap
Moderator: Mahmoud Ghannoum, PhD
10:00
am
From bunnies to babies: Bridging the gap
in candidiasis of the central nervous system
Thomas J. Walsh, MD
10:20 am
From guinea pigs to humans: What we have
learned regarding pulmonary aspergillosis?
Thomas F. Patterson, MD, FACP
10:40
am
Panel discussion
Session
III: Diagnosis
Moderator: Robert J. Rubin, MD
11:00
am
Novel diagnostic tests for invasive mould
infections (tissues and fluids)
Shigeru Kohno, MD, PhD
11:20 am
Radiology of fungal infections: When can
you tell whether the patient is improving?
Ronald C. Walker, MD
11:40
am
PET/CT: A new and powerful imaging tool
for the diagnosis of serious infections,
even during severe immunosuppression
Ronald C. Walker, MD
12:00
pm
Expert panel discussion on upcoming diagnostic
tests
12:10
pm
Lunch symposium
Session
IV: Management of fungal infections I: Candidiasis
Moderator: Carol A. Kauffman, MD
2:00
pm
Genitourinary candidiasis: An update on
pathogenesis and management
Jack D. Sobel, MD
2:20 pm
Risk factors for invasive candidiasis in
the ICU: A risk-stratification strategy
for prophylactic and pre-emptive therapy
Coleman M.F. Rotstein, MD, FRCPC, FACP,
FIDSA
2:40
pm
How I treat hematogenous candidiasis
John E. Edwards, MD
Session
V: Management of fungal infections II: Aspergillosis
& other invasive infections
Moderator: John R. Graybill, MD
3:00
pm
Epidemiology and management of Zygomycosis
Carol A. Kauffman, MD
3:20
pm
Update on other mould infections: Fusarium,
other agents of hyalohyphomycosis and
phaeohyphomycosis
Marcio Nucci, MD, PhD
3:40
pm
Endemic mycoses and cryptococcosis
Robert W. Bradsher, MD
4:00
pm
Panel discussion: Candidiasis and mould
infections
Session
VI: Presentation of awards
Moderators: Elias J. Anaissie, MD and Michael
G. Rinaldi, PhD
4:40
pm
Thomas J. Walsh Mycology Award (Sponsored
by Astellas Pharma US, Inc.)
Merck Young Investigator Award (Sponsored
by Merck & Co.)
4:50
pm
Poster viewing
Friday,
March 9, 2007
Session
VII: Antifungal trial design
Moderators: James Ito, MD and Jack D. Sobel,
MD
8:00
am
Candidiasis: Why we need to change our trial
strategy
Luis Ostrosky-Zeichner, MD, FACP
8:20
am
Antifungal trial design for mould-active
agents: Time to break the mold
Elias J. Anaissie, MD
8:40
am
Pharmacodynamics: A frequently forgotten
(essential) tool of antifungal trial design
George L. Drusano, MD
9:00
am
Pharmacogenomics of antifungal agents: An
update
David R. Andes, MD
9:20
am
Special lecture: TH1-TH2 in aspergillosis
David A. Stevens, MD
9:50
am
Panel discussion on antifungal trial design
10:10
am
Coffee break
Session
VIII: Management of fungal infections III:
The future of antifungal therapy?
Moderator: William E. Dismukes, MD
10:30
am
Mould-active azoles: Interaction with immunomodulators
and anti-cancer agents, comparative pharmacokinetics/dynamics
to include CNS penetration, food effect,
IV/PO
Paul O. Gubbins, PharmD
10:
50 am
Echinocandins: Comparative pharmacokinetics/dynamics
of caspofungin, micafungin
and anidulafungin with implications for
trial design and patient care
John R. Graybill, MD
11:10
am
Polyenes: Comparative properties of amphotericin
B deoxycholate and the lipid formulations
of amphotericin B with implications for
patient care
Speaker Invited
11:30
am
Panel discussion on the various classes
of antifungal agents
12:10
pm
Lunch symposium
Session
IX: Management of fungal infections in various
hosts: Lessons learned
Moderator: Kieren A. Marr, MD
2:00
pm
Immune reconstitution syndromes in invasive
fungal infections
John R. Perfect, MD
2:20 pm
Solid organ transplantation
Robert J. Rubin, MD
2:40
pm
Leukemia and bone marrow transplantation
John R. Wingard, MD
3:00
pm
Chronic granulomatous disease
Brahm H. Segal, MD
3:20
pm
Speaking words of wisdom: My 30-year experience
with fungal infections
William E. Dismukes, MD
4:00
pm
Adjourn
Michael G. Rinaldi, PhD
|
|
|
|
C O N T I N U I N G M E D I C A L
E D U C A T I O N |
|
|
|
Imedex®,
Inc. is accredited by the Accreditation
Council for Continuing Medical Education
to provide continuing medical education
for physicians.
Imedex,
Inc. designates this educational activity
for a maximum 14.0 of AMA PRA Category 1
Credit(s)TM. Physicians should only claim
credit commensurate with the extent of their
participation in the activity.
P.A.C.E.
accreditation
Imedex, Inc. has applied
for approval as a provider of continuing
education programs in the clinical laboratory
sciences through the ASCLS P.A.C.E.®
program. This is an advanced level instructional
program. If approved, this activity will
provide a maximum of 13 contact hours of
advanced continuing education in the clinical
laboratory sciences.
|
|
|
|
W H O S H O U L D A T T E N
D ? |
|
|
|
This
educational program is intended for physicians,
laboratory technologists and other healthcare
professionals with special education and
training in microbiology or infectious diseases
who are interested in the identification,
diagnosis, and management of fungal infections. |
|
|
|
O B J E C T I V E S |
|
|
|
After successful completion
of this program participants should be able
to:
-
List and identify the most important newly
emerging fungal pathogens
-
Discuss the relevance of clinical laboratory
findings for the diagnosis and management
of patients with invasive fungal infections
-
Recommend treatment for invasive fungal
infections in normal and at-risk populations
-
Summarize the characteristics of the newer
antifungal agents and clinical trial results
utilizing these agents
-
Comment on fungal infections in non-human
species and their relevance to the advances
in human
fungal infections
- Comment
on challenges in diagnosis and management
of fungal infections through challenging
case examples
-
Discuss the status of clinical trials
assessing the feasibility of combination
and sequential antifungal therapeutic
regimens
|
|
|
|
C A L L F O R A B S T R A C T
S |
|
|
Participants
interested in presenting data should submit abstracts
online here
by Friday, January 26, 2007. Abstracts are subject
to acceptance by the Scientific Committee. Once
accepted, abstracts will be published in the final
program book and scheduled for poster presentation.
Acceptance notifications and guidelines for poster
presentation will be sent on Monday, February
12, 2007. Authors of accepted abstracts who have
not registered will have until Wednesday, February
21, 2006 to do so at the rate of $275. After this
date, abstracts without registered presenters
will be disregarded.
Abstract
Guidelines
-
Follow the online instructions
-
Abstracts must be written in English
-
Accepted format: Word document format, 9 point
Arial font, 500 word count limit
-
Use a concise title
-
List affiliations of author(s) as briefly as possible,
with city, state and country
- Place
an asterisk (*) before the name of the presenting
author
-
Use standard and well-accepted abbreviations
-
When using references, use standard and well-accepted
formats
-
Abstract content should be single-spaced, typed
in lower case and contain:
+ Purpose of the study
+ Summarized description of the project
+ Results and conclusions
Submit
abstracts online here.
Submission Deadline:
Friday, January 26, 2007
Merck
Young Investigator Award (sponsored by Merck &
Co.)
This award is available
to assist with conference-related travel expenses
for fellows in training. The first author must
meet the following requirements:
-
The candidate for the award must be in training
at an approved Infectious Disease post-graduate
medical education program
-
Candidate must show original research of major
importance in the field of medical/clinical
mycology conducted by themselves and co-investigators
(if any)
- Candidate
must show relevance of the work to a current
problem in patients involving fungal infections
(in the broadest sense) in contemporary
medicine/veterinary medicine
- Candidate
must submit a well-written, concise and accurate
abstract
- Candidate
must register for the conference and agree to
be present during the scheduled poster presentation
times
- Candidate
must provide a letter of support from his/her
Program Director indicating their eligibility
for the award
- Check
Merit Award box on official abstract form
The
Thomas J. Walsh Mycology Award
The Thomas J. Walsh Mycology
Award was established to encourage and recognize
scientific research excellence. The award will
be presented to the best overall abstract presented
at Focus on Fungal Infections 17. The recipient
will be awarded a research grant of $15,000 for
utilization in their professional work. The first
author must meet the following requirements:
- Candidate
must show original research of major importance
in the field of medical/clinical mycology conducted
by themselves and co-investigators (if any)
- The
selected abstract should not have been presented
previous to Focus on Fungal Infections 17
- Candidate
must show relevance of the work to a current
problem in patients involving fungal infections
(in the broadest sense) in contemporary medicine
- Candidate
must submit a well-written, concise and accurate
abstract
- Candidate
must be registered for the meeting and agree
to be present during the scheduled presentation
times
|
|
|
|
R E G I S T R A T I O N |
|
|
| Click
here to register for this program
REGISTRATION
FEES
Physician and Other:
Discounted (If payment received by January
7, 2007) . . .
. . .$275
Regular (If payment received by February
28, 2007) . . .
. . .
$375
Full/Onsite (If payment received after February
28, 2007) . . .
$475
Group Discount (physicians only) . . .
. . .
. . . . .
. . . .
. . . . .
-$50
Pharmacists*:
Discounted (If payment
received by January 7, 2007) . . .
. . .$150
Regular (If payment received by February
28, 2007) . . .
. . .
.$200
Full/Onsite (If payment received after February
28, 2007) . . . $250
Group Discount . . .
. . .
. . . . .
. . . .
. . . . .
. . . .
. . . . .
. . . .
n/a
* Proof of pharmacist status required
To
Register: You
may register online
or call Imedex at +1 (770) 751 7332. Registration
confirmations will be issued before the
meeting.
To
qualify for special registration fees, registration
and full payment must be received by Imedex
by the dates specified. *To qualify for
pharmacist registration fees, proof of pharmacist
status required.
Multiple
physicians from the same institute or practice
each receive a $50 discount off the published
registration fees, provided all registration
forms and payments are received together.
Only one discount will apply per physician.
Discounts are not available for pharmacists’
rate.
Payment
Registration fees
can be remitted by credit card, check or
wire transfer. Checks should be payable
to Imedex. To pay via wire transfer, you
must add $25 to the registration fee to
cover bank charges. Include the full name
of the attendee and the name of the conference:
269 – Focus on Fungal Infections 17.
Attendee is not registered until full payment
is received.
Wire
to: Bank of America, ABA: 0260.0959.3, Account
Info: Imedex, Inc., Account: 0000.0106.3308.
If the wire originates outside the United
States, please add this additional information:
Clearing Bank:
Bank of America, New York, Swift Code: BOFAUS3N,
Clearing Account: 6550305831.
Registration
Fee Inclusions
Registration fees
include admittance to scientific sessions,
conference materials and all functions as
specified in the program.
Cancellation
For registration fees
to be refunded, written notice of cancellation
must be received at Imedex by February 28,
2007. The amount of registration fees remitted,
minus a $75 administrative charge, will
be refunded after the conference. Substitutions
are accepted with written notification.
After Febuary 28, 2007 no refunds will be
made.
Imedex
does not accept responsibility for covering
travel, accommodation or any other costs
incurred by registrants in the rare event
that this program should be cancelled for
any reason. Every effort will be made to
give reasonable notice in the event of cancellation.
The event program content is subject to
change without notice.
|
|
|
|
G E N E R A L I N F O R M A T I O N |
|
|
| DISCOUNTED
AIRFARES
Contact conference
travel agent, Age of Travel, for assistance
with your travel needs. Age of Travel can
also accommodate pre- and post-conference
extensions.
Tel.: +1 (800) 523 4954 or +1 (404) 591
7120
Email: Imedex@ageoftravel.com
CONFERENCE LOCATION
AND REGISTRATION HOURS
Manchester Grand Hyatt
San Diego
One Market Place
San Diego, California 92101 USA
Tel.: +1 (800) 233 1234 or +1 (402) 592
6462
Fax: +1 (619) 358 6279
The
Registration and Information Desk will be
staffed:
Wednesday, March 7, 2007 . . . . 12:00 pm
– 7:00 pm
Thursday, March 8, 2007 . . . .
. . .7:00
am – 5:00 pm
Friday, March 9, 2007 . . . .
. . .
. .7:00
am – 4:30 pm
|
|
|
|
H O T E L A C
C O M M O D A T I O N S |
|
|
|
Manchester
Grand Hyatt San Diego
One Market Place
San Diego, California 92101 USA
Tel.: +1 (800) 233 1234 or +1 (402) 592
6462
Fax: +1 (619) 358 6729
You
may reserve your accommodations online at:
www.manchestergrand.hyatt.com
Enter group code: G-IMED
The
Manchester Grand Hyatt San Diego is now
the largest and tallest hotel on the West
Coast waterfront and certainly the most
grand. This elegant hotel affords the best
of everything for today’s discerning
traveler, from unparalleled convenience
and breathtaking views to superb accommodations
and resort-style amenities. The Manchester
Grand Hyatt will provide an unforgettable
experience and the perfect starting place
to discover all the excitement of this world-class
city.
For
the convenience of attendees, a limited
number of rooms have been reserved at a
rate of $235.00, single or standard occupancy,
plus tax, currently at 10.5%. These rooms
will be held until Monday, February 14,
2007. This rate is not guaranteed outside
the conference dates.
Please
contactthe Manchester Grand Hyatt San Diego
hotel directly to book your accommodations
and mention the conference reference "Imedex"
to receive the discounted room rate.
Hotel
Cancellation:
Attendees wishing
to cancel their accommodations are allowed
to do so without penalty if the cancellation
request is received by hotel a minimum of
5 days prior to the scheduled arrival date.
|
|
|
|
O R G A N I Z E R |
|
|
|
|
©
2006 Imedex®, Inc. |
|
